Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NVO - Zepbound shortage: Eli Lilly's weight-loss drug in limited availability through April-end

NVO - Zepbound shortage: Eli Lilly's weight-loss drug in limited availability through April-end

Novo Nordisk A/S

2024-04-03 12:05:29 ET

Eli Lilly’s ( NYSE: LLY ) weight-loss drug Zepbound (tirzepatide) will remain in short supply through April-end amid increased demand, the U.S. Food and Drug Administration (FDA) confirmed on Wednesday....

For further details see:

Zepbound shortage: Eli Lilly's weight-loss drug in limited availability through April-end
Stock Information
Company Name: Novo Nordisk A/S
Stock Symbol: NVO
Market: NYSE
Website: novonordisk.com
Menu
NVO NVO Quote NVO Short NVO News NVO Articles NVO Message Board
Get NVO Alerts

News, Short Squeeze, Breakout and More Instantly...